SCHEMBL30937474

SCHEMBL30937474

N#C/C(=C\c1cccnc1)c1c[nH]c2ccc(O)cc12

nearest known ligand 0.78

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 10/20 0.78
CLK1 P49759 9/20 0.78
KIF20A O95235 10/20 0.74
CLK2 P49760 2/20 0.64
CLK4 Q9HAZ1 2/20 0.64
DYRK1B Q9Y463 2/20 0.64
CDK5 Q00535 1/20 0.64
CDK5R1 Q15078 1/20 0.64
PIP4K2A P48426 1/20 0.49
MAPT P10636 3/20 0.48
KDM4E B2RXH2 2/20 0.48
ALDH1A1 P00352 2/20 0.48
KMT2A Q03164 2/20 0.48
MEN1 O00255 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
MAPK1 P28482 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2711278 1.00 DYRK1A (0.78) DYRK1ACLK1KIF20ACLK2CLK4
SCHEMBL2711280 1.00 DYRK1A (0.78) DYRK1ACLK1KIF20ACLK2CLK4
SCHEMBL19192706 0.88 DYRK1A (0.60) DYRK1ACLK1KIF20ACLK2CLK4
SCHEMBL19192548 0.87 DYRK1A (0.76) DYRK1ACLK1KIF20ACLK2CLK4
SCHEMBL2725098 0.87 DYRK1A (0.76) DYRK1ACLK1KIF20ACLK2CLK4
SCHEMBL2725265 0.87 DYRK1A (0.76) DYRK1ACLK1KIF20ACLK2CLK4
SCHEMBL2726304 0.87 DYRK1A (1.00) DYRK1ACLK1KIF20ACLK2CLK4
SCHEMBL2726290 0.87 DYRK1A (1.00) DYRK1ACLK1KIF20ACLK2CLK4
SCHEMBL2725264 0.87 DYRK1A (0.76) DYRK1ACLK1KIF20ACLK2CLK4
SCHEMBL2726292 0.87 DYRK1A (1.00) DYRK1ACLK1KIF20ACLK2CLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4629988-A1 DERIVATIVES OF INDOLE FOR THE TREATMENT OF CANCER AND INFECTIONS Centre National de la Recherche Scientifique (FR) 2025-10-15 EP disclosed
WO-2024121072-A1 DERIVATIVES OF INDOLE FOR THE TREATMENT OF CANCER AND INFECTIONS CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2024-06-13 WO disclosed